I won't judge you for going down the rabbit hole online
To move Epitalon from experimental to evidence-based, several developments are essential: Randomized, double-blind, placebo-controlled clinical trials, ideally targeting specific endpoints (sleep, immune aging, telomere attrition) Toxicology and long-term safety studies, including exploration of stereoisomer effects and off-target consequences Validated delivery systems (e.g., dendrimer-conjugates, transdermal patches) that make real-world use feasible Pharmacodynamic biomarkers, to identify responders and track efficacy objectively over time Epitalon is not snake oil, but its also not a magic bullet
The most common side effects are nausea, vomiting, diarrhoea, constipation, and abdominal discomfort, which may be particularly troublesome for fibromyalgia patients who often experience irritable bowel syndrome
Early on, tirzepatide may produce 23 pounds of loss weekly
The 90-day starter plan provides structured initiation for patients beginning their Tirzepatide journey
Additionally, many patients experience weight loss, addressing a common comorbidity of type 2 diabetes